AutoEPAP

Press Releases

ResMed’s Astral Life Support Ventilator Now Has AutoEPAP in U.S.

SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD) (ASX: RMD), a global leader in cloud-connected respiratory care devices, today announced key upgrades to its Astral life support ventilators, including Optional AutoEPAP in iVAPS for U.S. patients, a high-demand therapy option. AutoEPAP now available for U.S. Astral ventilator users, plus worldwide upgrades for ease of use and peace of mind. #respiratorycare Tweet this What…